Wet age-related macular degeneration is an eye condition that occurs when abnormal blood vessels start to grow beneath the retina. Outlook, which received regulatory approval earlier this year in the ...

In a study, a team of Korean researchers developed an AI model using OCT images to predict neovascular AMD treatment outcomes after anti-VEGF injections. The model highlights AI’s potential in ...

Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the ...

Final efficacy data expected in January 2025Anticipate resubmission of BLA in calendar Q1 2025 ISELIN, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a ...

Follow the Company on its website, LinkedIn, or X. The Ocular Therapeutix logo and DEXTENZA® are registered trademarks of Ocular Therapeutix, Inc. AXPAXLITM, PAXTRAVATM, ELUTYXTM, and Ocular ...

Oranges, grapefruit and lemons – these citrus fruits are full of Vitamin C which can help prevent age-related macular ...

Detailed price information for Adverum Biotechnologies Inc (ADVM-Q) from The Globe and Mail including charting and trades.

Induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency could transform eye care and ...

Fast Track designation indicates LBS-007’s potential in filling the unmet medical need of acute leukemiaLBS-007 is the Company’s investigational ...

Quest Partners LLC reduced its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 42.7% in the third quarter, according to the company in its most recent 13F filing with the Securities ...

As we get older, we tend to assume that certain things like aches and strains after strenuous activity are inevitable. But, just as stretching before and after a workout or other physical activity can ...